Drug Shortage Report for APO-TERIFLUNOMIDE
Report ID | 208385 |
Drug Identification Number | 02500639 |
Brand name | APO-TERIFLUNOMIDE |
Common or Proper name | TERIFLUNOMIDE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TERIFLUNOMIDE |
Strength(s) | 14MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 BLS |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-24 |
Estimated end date | 2024-01-19 |
Actual end date | 2024-01-11 |
Shortage status | Resolved |
Updated date | 2024-01-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-01-12 | French | Compare |
v5 | 2024-01-12 | English | Compare |
v4 | 2023-12-15 | French | Compare |
v3 | 2023-12-15 | English | Compare |
v2 | 2023-10-27 | French | Compare |
v1 | 2023-10-27 | English | Compare |
Showing 1 to 6 of 6